accord
appear
kda
speci
sdspage
lectin
galectin
solubl
bind
protein
secretori
glycoprotein
initi
identifi
tumor
antigen
upregul
context
breast
lung
carcinoma
physiolog
function
extracellular
compris
modul
cell
migrat
adhes
interact
multipl
cell
surfac
receptor
includ
modul
activ
immun
cell
healthi
individu
protein
reach
concentr
rang
divers
bodi
fluid
sinc
share
mrna
upregul
tcell
infect
individu
type
ifninduc
express
establish
restrict
factor
includ
function
screen
candid
isg
antivir
activ
goffinet
unpublish
data
act
antivir
reduc
particl
infect
newli
produc
virion
defect
accompani
impair
incorpor
env
glycoprotein
viru
particl
probabl
explain
reduc
infecti
qualiti
de
novosynthes
virion
defect
process
env
precursor
matur
protein
addit
exogen
solubl
produc
cell
cultur
fail
inhibit
particl
infect
suggest
exert
antivir
effect
intracellularli
outsidein
signal
extracellular
dispens
antivir
function
analysi
set
modifi
variant
reveal
two
central
proteinbind
domain
btbpoz
ivr
requir
suffici
antivir
activ
sinc
delet
ntermin
scaveng
receptor
cystein
rich
srcr
like
domain
ctermin
domain
abolish
antivir
activ
exact
mode
action
remain
elus
date
experiment
data
argu
virion
incorpor
given
env
share
subcellular
local
posttransl
matur
secretori
pathway
interfer
env
incorpor
model
target
env
either
via
direct
indirect
interact
favor
howev
coip
experi
fail
far
provid
evid
detect
interact
env
thu
indirect
scenario
inhibit
function
express
cellular
viral
factor
requir
effici
env
incorpor
exclud
although
express
induc
process
defect
env
precursor
result
high
cellassoci
level
uncleav
polyprotein
small
fraction
matur
remain
unclear
whether
process
defect
direct
caus
poor
incorpor
matur
glycoprotein
whether
two
inhibitori
action
genet
andor
function
uncoupl
futur
work
need
clarifi
exact
mode
action
human
target
cell
protein
express
highli
celltyp
specif
readili
detect
primari
monocytederiv
macrophag
importantli
sirnamedi
knockdown
facilit
spread
cultur
primari
macrophag
increas
particl
infect
newli
produc
virion
indic
endogen
express
level
contribut
control
spread
import
target
cell
type
strike
contrast
protein
undetect
primari
tcell
analyz
immort
tcell
line
even
use
sensit
elisa
assay
despit
type
ifnmedi
upregul
mrna
suggest
express
tightli
repress
posttranscript
level
tcell
given
specif
express
macrophag
within
target
cell
type
fulli
support
viru
replic
predict
vivo
import
difficult
express
level
protein
serum
correl
viral
load
high
express
level
viral
setpoint
predict
neg
outcom
infect
although
seem
contradict
protect
role
host
infect
posit
correl
isg
express
viral
load
longappreci
observ
rais
possibl
sustain
upregul
type
ifn
chronic
phase
infect
indirectli
promot
virusbenefici
effect
addit
direct
antivir
effect
type
ifninduc
isg
may
protect
acut
infect
addit
import
take
consider
level
solubl
may
necessarili
reflect
level
cellassoci
antivir
protein
fraction
along
line
potenti
evas
mechan
still
need
defin
keep
densiti
glycoprotein
molecul
viru
surfac
low
properti
virus
particularli
pronounc
thought
provid
select
advantag
immun
evas
unclear
whether
drawback
reduct
virion
infect
induc
pauciti
env
embed
particl
outweigh
improv
immun
escap
work
warrant
fulli
understand
impact
infect
ifitm
protein
small
twopass
transmembran
protein
locat
predominantli
plasma
membran
endosom
lysosom
membran
belong
protein
superfamili
exist
throughout
kingdom
includ
bacteria
invertebr
primat
addit
famili
member
includ
whose
express
restrict
osteoblast
addit
recent
discov
human
ifitm
gene
probabl
contribut
inhibit
infect
yet
test
antivir
activ
respect
almost
ubiquit
express
express
upregul
type
ifn
ifitm
protein
contribut
regul
earli
develop
cell
adhes
control
cell
growth
interest
ifitm
protein
steepli
rais
upon
first
descript
antivir
activ
influenza
viru
flavivirus
includ
west
nile
viru
dengu
viru
indic
broad
antivir
activ
small
factor
target
ifitm
protein
coronavirus
hepat
c
viru
ebola
viru
vesicular
stomat
viru
vsv
well
bunyavirus
reovirus
appear
express
ifitm
protein
target
cell
suffici
inhibit
virus
specif
interfer
glycoproteindepend
fusion
viral
endosom
membran
prevent
deliveri
viral
genom
cytoplasm
result
trap
virion
endosom
lysosom
degrad
strikingli
minor
snp
human
lead
express
ntermin
truncat
protein
strongli
associ
poor
prognosi
pandem
influenza
infect
find
highlight
import
contribut
defend
human
viral
pathogen
infect
establish
bonafid
antivir
factor
impact
ifitm
protein
singleround
infect
discuss
controversi
use
rnai
antivir
activ
found
unlik
exist
sinc
inhibit
cellfre
observ
hela
cell
endogen
express
although
ifitm
protein
score
posit
largescal
screen
antivir
activ
detect
antivir
effect
must
probabl
attribut
vsvgmediat
entri
employ
pseudotyp
lack
authent
env
modest
consequ
overexpress
absent
antivir
activ
report
use
blamvprbas
fusion
assay
suggest
fusion
cellfre
weakli
affect
contrast
moder
effect
ifitm
protein
singleround
infect
stabl
express
individu
ifitm
protein
tcell
line
effect
imped
viral
spread
cell
cultur
use
replicationcompet
impli
potent
effector
function
ifitm
protein
system
celltocel
transmiss
predomin
inde
find
two
independ
group
recent
shed
light
potenti
mechan
wherea
express
membran
target
cell
fail
exert
antivir
activ
context
celltocel
transmiss
antivir
capac
obviou
express
infect
donor
cell
transmit
viru
ifitmneg
target
cell
antivir
effect
potenti
ifitm
express
donor
target
cell
specif
ifitm
protein
incorpor
membran
nascent
virion
therebi
decreas
particl
infect
impair
fusion
appar
expens
env
incorpor
also
envdepend
manner
exact
mode
action
virusassoci
ifitm
whether
virion
incorpor
ifitm
protein
govern
specif
determin
occur
randomli
whether
ifitm
protein
incorpor
viru
particl
famili
remain
yet
investig
context
virus
multipl
partial
contradict
model
debat
suggest
ifitm
protein
inhibit
fusogen
membran
locat
specif
may
restrict
influenza
viru
entri
restrict
viral
membran
hemifus
block
format
fusion
pore
posthemifus
stage
altern
hypothesi
say
disrupt
cholesterol
homeostasi
lead
accumul
cholesterol
intracellular
compart
altern
viral
incorpor
ifitm
protein
may
caus
exclus
inclus
yet
defin
specif
cellular
factor
antivir
activ
consequ
although
evid
direct
viral
antagonist
ifitm
protein
lack
may
abl
overcom
ifitmimpos
antivir
activ
sinc
evas
mutat
vpu
env
report
passag
tcell
line
among
accessori
gene
primat
lentivirus
nef
display
probabl
highest
degre
multifunction
evidenc
infect
inactiv
nef
mutat
delet
rhesu
macaqu
human
intact
nef
gene
requir
vivo
sustain
viremia
develop
immunodefici
although
nef
exert
enzymat
activ
fulfil
multitud
function
culmin
alter
cell
signal
activ
interf
cellular
vesicular
traffick
machineri
associ
nef
membran
govern
myristoyl
also
incorpor
viru
particl
downregul
sever
cell
surfac
receptor
includ
coreceptor
well
mhc
class
ii
receptor
modul
transcript
activ
infect
tcell
establish
function
nef
anoth
longappreci
activ
nef
enhanc
particl
infect
product
devoid
intact
nef
gene
result
impair
particl
infect
rang
reduc
titer
depend
produc
cell
type
target
cell
type
viral
isol
pronounc
requir
nef
seen
lymphoid
cell
nefmedi
enhanc
particl
infect
requir
express
produc
cell
highli
conserv
within
primat
lentivirus
maintain
diseas
progress
fact
nef
incorpor
virion
cleav
proteas
matur
particl
may
support
specif
function
virusincorpor
nef
manifest
earli
next
round
infect
membran
associ
may
suffici
result
virion
packag
sinc
nef
also
found
ortholog
retrovirus
coexpress
produc
cell
recent
mechan
nefmedi
infect
enhanc
elucid
use
differenti
mrna
sequenc
differ
produc
cell
line
differ
requir
nef
optim
infect
mass
spectrometrybas
approach
respect
member
serin
incorpor
serinc
famili
identifi
potent
cellular
inhibitor
retrovirion
particl
infect
absenc
nef
serinc
protein
highli
conserv
multipass
transmembran
protein
express
predominantli
plasma
membran
poorli
elucid
cellular
function
besid
mediat
serin
incorpor
phosphatidylserin
sphingolipid
abundantli
express
pbmc
report
inhibit
absenc
nef
dosedepend
synergist
fashion
appear
requir
serinc
incorpor
virion
inhibit
act
specif
envcontain
particl
sinc
vsvg
pseudotyp
larg
insensit
nef
shown
counteract
serinc
activ
downregul
cell
surfac
via
clathrindepend
endocytosi
sequest
endosom
thu
preclud
incorpor
virion
particl
interestingli
prototyp
retroviru
mlv
evolv
antagonist
glycogag
counteract
underlin
import
antivir
factor
interestingli
express
induc
stimul
type
interferon
contrast
target
viral
antagonist
antivir
activ
appear
caus
predominantli
postentri
defect
sinc
detect
slight
inhibit
viruscel
fusion
probabl
fulli
account
far
pronounc
infect
decreas
impos
physiolog
level
express
futur
work
need
fulli
understand
antivir
mode
action
serinc
protein
deciph
whether
envelop
virus
prone
serincmedi
inhibit
exactli
nef
counteract
serinc
protein
notabl
better
understand
serincimpos
antivir
block
infect
potenti
nefserinc
interfac
might
translat
design
small
antivir
molecul
interrupt
nefserinc
interact
allow
fullblown
serincmedi
inhibit
past
decad
discoveri
character
antivir
restrict
factor
catapult
understand
cellintrins
immun
wherea
mani
antivir
factor
found
target
earli
postentri
step
replic
cycl
recent
find
uncov
potenti
cellular
protein
member
ifitm
serinc
protein
famili
reduc
particl
infect
act
modifi
essenti
particl
composit
incorpor
nascent
virion
respect
exist
may
least
partial
contribut
inher
high
frequenc
uninfecti
particl
extens
investig
requir
fulli
understand
mode
action
respect
virallyencod
antagonist
evas
strategi
open
excit
new
area
research
potenti
translat
design
new
antivir
treatment
strategi
